P&G’s shares rose 5.6% after earnings, with investors responding to 4.0% organic sales growth, led by volume, and broad-based gains across categories and regions. The quarter also showed pressure underneath the top line: core operating margin fell 80 basis points as productivity was offset by higher commodity and freight costs and demand-creation investment.
Shares of Procter & Gamble declined 3.3% following earnings as investors reacted negatively to lower core EPS and margin compression driven by cost pressures and trade dynamics, despite stable organic sales growth.
Procter & Gamble reported a challenging second quarter with organic sales growth primarily driven by international markets, but expects stronger performance in the latter half of the fiscal year due to strategic innovations and productivity improvements.
Procter & Gamble demonstrated solid resilience in fiscal year 2025, achieving a 2% organic sales growth and a 4% increase in core EPS amid challenging market conditions. Strategic leadership transitions position the company for continued growth.